nodes	percent_of_prediction	percent_of_DWPC	metapath
Carteolol—CYP2D6—Temsirolimus—kidney cancer	0.233	0.372	CbGbCtD
Carteolol—CYP2D6—Pazopanib—kidney cancer	0.122	0.195	CbGbCtD
Carteolol—CYP2D6—Erlotinib—kidney cancer	0.0873	0.139	CbGbCtD
Carteolol—CYP2D6—Sorafenib—kidney cancer	0.071	0.113	CbGbCtD
Carteolol—CYP2D6—Vinblastine—kidney cancer	0.0701	0.112	CbGbCtD
Carteolol—CYP2D6—Doxorubicin—kidney cancer	0.0431	0.0687	CbGbCtD
Carteolol—Rash generalised—Temsirolimus—kidney cancer	0.0139	0.0374	CcSEcCtD
Carteolol—Rash generalised—Pazopanib—kidney cancer	0.0131	0.0353	CcSEcCtD
Carteolol—Rash generalised—Everolimus—kidney cancer	0.0104	0.0278	CcSEcCtD
Carteolol—Rash generalised—Sunitinib—kidney cancer	0.00866	0.0233	CcSEcCtD
Carteolol—Keratitis—Erlotinib—kidney cancer	0.00655	0.0176	CcSEcCtD
Carteolol—Rash generalised—Paclitaxel—kidney cancer	0.00581	0.0156	CcSEcCtD
Carteolol—Diabetes mellitus—Temsirolimus—kidney cancer	0.00494	0.0133	CcSEcCtD
Carteolol—Cardiac failure congestive—Pazopanib—kidney cancer	0.00447	0.012	CcSEcCtD
Carteolol—Photophobia—Vinblastine—kidney cancer	0.00415	0.0112	CcSEcCtD
Carteolol—Cerebrovascular accident—Pazopanib—kidney cancer	0.00413	0.0111	CcSEcCtD
Carteolol—Lacrimation increased—Sunitinib—kidney cancer	0.00399	0.0107	CcSEcCtD
Carteolol—Keratitis—Paclitaxel—kidney cancer	0.00381	0.0102	CcSEcCtD
Carteolol—Respiratory failure—Sunitinib—kidney cancer	0.00375	0.0101	CcSEcCtD
Carteolol—Diabetes mellitus—Everolimus—kidney cancer	0.00368	0.00988	CcSEcCtD
Carteolol—Cardiac failure congestive—Everolimus—kidney cancer	0.00353	0.00947	CcSEcCtD
Carteolol—Depression—Temsirolimus—kidney cancer	0.0033	0.00888	CcSEcCtD
Carteolol—Hypoglycaemia—Everolimus—kidney cancer	0.00328	0.0088	CcSEcCtD
Carteolol—Cerebrovascular accident—Vinblastine—kidney cancer	0.00328	0.0088	CcSEcCtD
Carteolol—Conjunctivitis—Temsirolimus—kidney cancer	0.00322	0.00865	CcSEcCtD
Carteolol—Respiratory failure—Vincristine—kidney cancer	0.00317	0.00852	CcSEcCtD
Carteolol—Cerebrovascular accident—Erlotinib—kidney cancer	0.00315	0.00846	CcSEcCtD
Carteolol—Keratitis—Capecitabine—kidney cancer	0.00313	0.0084	CcSEcCtD
Carteolol—Sinusitis—Temsirolimus—kidney cancer	0.00311	0.00835	CcSEcCtD
Carteolol—Cardiac failure congestive—Sorafenib—kidney cancer	0.00306	0.00822	CcSEcCtD
Carteolol—Respiratory failure—Gemcitabine—kidney cancer	0.00301	0.00808	CcSEcCtD
Carteolol—Cardiac failure congestive—Sunitinib—kidney cancer	0.00295	0.00791	CcSEcCtD
Carteolol—Eye irritation—Paclitaxel—kidney cancer	0.00289	0.00778	CcSEcCtD
Carteolol—Bradycardia—Pazopanib—kidney cancer	0.00285	0.00766	CcSEcCtD
Carteolol—Hypoglycaemia—Sunitinib—kidney cancer	0.00274	0.00735	CcSEcCtD
Carteolol—Cerebrovascular accident—Sunitinib—kidney cancer	0.00273	0.00732	CcSEcCtD
Carteolol—Bronchospasm—Everolimus—kidney cancer	0.00272	0.0073	CcSEcCtD
Carteolol—Lacrimation increased—Paclitaxel—kidney cancer	0.00268	0.00721	CcSEcCtD
Carteolol—Atrioventricular block—Paclitaxel—kidney cancer	0.00255	0.00685	CcSEcCtD
Carteolol—Dysgeusia—Temsirolimus—kidney cancer	0.00254	0.00681	CcSEcCtD
Carteolol—Respiratory failure—Paclitaxel—kidney cancer	0.00252	0.00676	CcSEcCtD
Carteolol—Depression—Vinblastine—kidney cancer	0.00247	0.00663	CcSEcCtD
Carteolol—Conjunctivitis—Everolimus—kidney cancer	0.0024	0.00644	CcSEcCtD
Carteolol—Dysgeusia—Pazopanib—kidney cancer	0.00239	0.00642	CcSEcCtD
Carteolol—Eye irritation—Capecitabine—kidney cancer	0.00238	0.00638	CcSEcCtD
Carteolol—Depression—Erlotinib—kidney cancer	0.00237	0.00637	CcSEcCtD
Carteolol—Cardiac failure congestive—Gemcitabine—kidney cancer	0.00236	0.00635	CcSEcCtD
Carteolol—Sinusitis—Everolimus—kidney cancer	0.00231	0.00621	CcSEcCtD
Carteolol—Conjunctivitis—Erlotinib—kidney cancer	0.00231	0.00621	CcSEcCtD
Carteolol—Vision blurred—Pazopanib—kidney cancer	0.0023	0.00618	CcSEcCtD
Carteolol—Lacrimation—Doxorubicin—kidney cancer	0.00222	0.00598	CcSEcCtD
Carteolol—Lacrimation increased—Capecitabine—kidney cancer	0.0022	0.00591	CcSEcCtD
Carteolol—Syncope—Pazopanib—kidney cancer	0.00219	0.00588	CcSEcCtD
Carteolol—Cerebrovascular accident—Gemcitabine—kidney cancer	0.00219	0.00588	CcSEcCtD
Carteolol—Loss of consciousness—Pazopanib—kidney cancer	0.00214	0.00576	CcSEcCtD
Carteolol—Oedema—Temsirolimus—kidney cancer	0.00211	0.00568	CcSEcCtD
Carteolol—Depression—Sunitinib—kidney cancer	0.00205	0.00551	CcSEcCtD
Carteolol—Keratitis—Doxorubicin—kidney cancer	0.00202	0.00542	CcSEcCtD
Carteolol—Oedema—Pazopanib—kidney cancer	0.00199	0.00535	CcSEcCtD
Carteolol—Cardiac failure congestive—Paclitaxel—kidney cancer	0.00198	0.00532	CcSEcCtD
Carteolol—Shock—Pazopanib—kidney cancer	0.00196	0.00526	CcSEcCtD
Carteolol—Insomnia—Temsirolimus—kidney cancer	0.00191	0.00513	CcSEcCtD
Carteolol—Arrhythmia—Erlotinib—kidney cancer	0.00191	0.00512	CcSEcCtD
Carteolol—Visual disturbance—Paclitaxel—kidney cancer	0.00189	0.00509	CcSEcCtD
Carteolol—Dysgeusia—Everolimus—kidney cancer	0.00189	0.00507	CcSEcCtD
Carteolol—Dyspnoea—Temsirolimus—kidney cancer	0.00188	0.00506	CcSEcCtD
Carteolol—Bradycardia—Sunitinib—kidney cancer	0.00188	0.00505	CcSEcCtD
Carteolol—Hypoglycaemia—Paclitaxel—kidney cancer	0.00184	0.00494	CcSEcCtD
Carteolol—Cerebrovascular accident—Paclitaxel—kidney cancer	0.00183	0.00492	CcSEcCtD
Carteolol—Bronchospasm—Gemcitabine—kidney cancer	0.00182	0.0049	CcSEcCtD
Carteolol—Vision blurred—Everolimus—kidney cancer	0.00181	0.00488	CcSEcCtD
Carteolol—Insomnia—Pazopanib—kidney cancer	0.0018	0.00484	CcSEcCtD
Carteolol—Dyspnoea—Pazopanib—kidney cancer	0.00177	0.00477	CcSEcCtD
Carteolol—Depression—Vincristine—kidney cancer	0.00174	0.00466	CcSEcCtD
Carteolol—Syncope—Everolimus—kidney cancer	0.00173	0.00464	CcSEcCtD
Carteolol—Arrhythmia—Sorafenib—kidney cancer	0.00172	0.00461	CcSEcCtD
Carteolol—Palpitations—Everolimus—kidney cancer	0.0017	0.00457	CcSEcCtD
Carteolol—Diabetes mellitus—Capecitabine—kidney cancer	0.00169	0.00455	CcSEcCtD
Carteolol—Loss of consciousness—Everolimus—kidney cancer	0.00169	0.00455	CcSEcCtD
Carteolol—Syncope—Erlotinib—kidney cancer	0.00167	0.00448	CcSEcCtD
Carteolol—Arrhythmia—Sunitinib—kidney cancer	0.00165	0.00444	CcSEcCtD
Carteolol—Dysgeusia—Sorafenib—kidney cancer	0.00164	0.0044	CcSEcCtD
Carteolol—Loss of consciousness—Erlotinib—kidney cancer	0.00163	0.00439	CcSEcCtD
Carteolol—Dysgeusia—Sunitinib—kidney cancer	0.00158	0.00423	CcSEcCtD
Carteolol—Oedema—Everolimus—kidney cancer	0.00157	0.00422	CcSEcCtD
Carteolol—Hypersensitivity—Temsirolimus—kidney cancer	0.00156	0.00418	CcSEcCtD
Carteolol—Shock—Everolimus—kidney cancer	0.00155	0.00415	CcSEcCtD
Carteolol—Oedema—Erlotinib—kidney cancer	0.00152	0.00407	CcSEcCtD
Carteolol—Asthenia—Temsirolimus—kidney cancer	0.00152	0.00407	CcSEcCtD
Carteolol—Cerebrovascular accident—Capecitabine—kidney cancer	0.0015	0.00404	CcSEcCtD
Carteolol—Syncope—Sorafenib—kidney cancer	0.0015	0.00403	CcSEcCtD
Carteolol—Shock—Erlotinib—kidney cancer	0.00149	0.00401	CcSEcCtD
Carteolol—Diplopia—Capecitabine—kidney cancer	0.00147	0.00396	CcSEcCtD
Carteolol—Loss of consciousness—Sorafenib—kidney cancer	0.00147	0.00395	CcSEcCtD
Carteolol—Hypotension—Everolimus—kidney cancer	0.00147	0.00395	CcSEcCtD
Carteolol—Asthenia—Pazopanib—kidney cancer	0.00143	0.00384	CcSEcCtD
Carteolol—Insomnia—Everolimus—kidney cancer	0.00142	0.00382	CcSEcCtD
Carteolol—Lacrimation increased—Doxorubicin—kidney cancer	0.00142	0.00381	CcSEcCtD
Carteolol—Dyspnoea—Everolimus—kidney cancer	0.0014	0.00377	CcSEcCtD
Carteolol—Dizziness—Temsirolimus—kidney cancer	0.0014	0.00375	CcSEcCtD
Carteolol—Depression—Paclitaxel—kidney cancer	0.00138	0.0037	CcSEcCtD
Carteolol—Insomnia—Erlotinib—kidney cancer	0.00137	0.00369	CcSEcCtD
Carteolol—Dyspnoea—Erlotinib—kidney cancer	0.00135	0.00363	CcSEcCtD
Carteolol—Atrioventricular block—Doxorubicin—kidney cancer	0.00135	0.00362	CcSEcCtD
Carteolol—Conjunctivitis—Paclitaxel—kidney cancer	0.00134	0.00361	CcSEcCtD
Carteolol—Shock—Sorafenib—kidney cancer	0.00134	0.00361	CcSEcCtD
Carteolol—Arrhythmia—Gemcitabine—kidney cancer	0.00132	0.00356	CcSEcCtD
Carteolol—Headache—Temsirolimus—kidney cancer	0.00132	0.00356	CcSEcCtD
Carteolol—Dizziness—Pazopanib—kidney cancer	0.00132	0.00354	CcSEcCtD
Carteolol—Oedema—Sunitinib—kidney cancer	0.00131	0.00353	CcSEcCtD
Carteolol—Sinusitis—Paclitaxel—kidney cancer	0.0013	0.00349	CcSEcCtD
Carteolol—Shock—Sunitinib—kidney cancer	0.00129	0.00347	CcSEcCtD
Carteolol—Bradycardia—Paclitaxel—kidney cancer	0.00126	0.0034	CcSEcCtD
Carteolol—Nausea—Temsirolimus—kidney cancer	0.00126	0.00337	CcSEcCtD
Carteolol—Bronchospasm—Capecitabine—kidney cancer	0.00125	0.00336	CcSEcCtD
Carteolol—Headache—Pazopanib—kidney cancer	0.00125	0.00335	CcSEcCtD
Carteolol—Oedema—Dactinomycin—kidney cancer	0.00124	0.00334	CcSEcCtD
Carteolol—Dyspnoea—Sorafenib—kidney cancer	0.00122	0.00327	CcSEcCtD
Carteolol—Visual impairment—Paclitaxel—kidney cancer	0.0012	0.00321	CcSEcCtD
Carteolol—Insomnia—Sunitinib—kidney cancer	0.00119	0.00319	CcSEcCtD
Carteolol—Nausea—Pazopanib—kidney cancer	0.00118	0.00318	CcSEcCtD
Carteolol—Dyspnoea—Sunitinib—kidney cancer	0.00117	0.00314	CcSEcCtD
Carteolol—Hypersensitivity—Vinblastine—kidney cancer	0.00116	0.00312	CcSEcCtD
Carteolol—Hypersensitivity—Everolimus—kidney cancer	0.00116	0.00311	CcSEcCtD
Carteolol—Asthenia—Vinblastine—kidney cancer	0.00113	0.00304	CcSEcCtD
Carteolol—Depression—Capecitabine—kidney cancer	0.00113	0.00304	CcSEcCtD
Carteolol—Asthenia—Everolimus—kidney cancer	0.00113	0.00303	CcSEcCtD
Carteolol—Oedema—Vincristine—kidney cancer	0.00111	0.00298	CcSEcCtD
Carteolol—Arrhythmia—Paclitaxel—kidney cancer	0.00111	0.00298	CcSEcCtD
Carteolol—Conjunctivitis—Capecitabine—kidney cancer	0.0011	0.00296	CcSEcCtD
Carteolol—Diabetes mellitus—Doxorubicin—kidney cancer	0.00109	0.00293	CcSEcCtD
Carteolol—Asthenia—Erlotinib—kidney cancer	0.00109	0.00292	CcSEcCtD
Carteolol—Dysgeusia—Paclitaxel—kidney cancer	0.00106	0.00284	CcSEcCtD
Carteolol—Oedema—Gemcitabine—kidney cancer	0.00105	0.00283	CcSEcCtD
Carteolol—Cardiac failure congestive—Doxorubicin—kidney cancer	0.00105	0.00281	CcSEcCtD
Carteolol—Dizziness—Vinblastine—kidney cancer	0.00104	0.0028	CcSEcCtD
Carteolol—Dizziness—Everolimus—kidney cancer	0.00104	0.00279	CcSEcCtD
Carteolol—Hypotension—Vincristine—kidney cancer	0.00104	0.00279	CcSEcCtD
Carteolol—Bradycardia—Capecitabine—kidney cancer	0.00104	0.00279	CcSEcCtD
Carteolol—Vision blurred—Paclitaxel—kidney cancer	0.00102	0.00274	CcSEcCtD
Carteolol—Hypersensitivity—Sorafenib—kidney cancer	0.00101	0.0027	CcSEcCtD
Carteolol—Insomnia—Vincristine—kidney cancer	0.001	0.0027	CcSEcCtD
Carteolol—Dizziness—Erlotinib—kidney cancer	0.001	0.00269	CcSEcCtD
Carteolol—Headache—Vinblastine—kidney cancer	0.000988	0.00266	CcSEcCtD
Carteolol—Headache—Everolimus—kidney cancer	0.000985	0.00265	CcSEcCtD
Carteolol—Hypotension—Gemcitabine—kidney cancer	0.000984	0.00264	CcSEcCtD
Carteolol—Visual impairment—Capecitabine—kidney cancer	0.000982	0.00264	CcSEcCtD
Carteolol—Asthenia—Sorafenib—kidney cancer	0.000979	0.00263	CcSEcCtD
Carteolol—Hypoglycaemia—Doxorubicin—kidney cancer	0.000973	0.00261	CcSEcCtD
Carteolol—Syncope—Paclitaxel—kidney cancer	0.000969	0.0026	CcSEcCtD
Carteolol—Cerebrovascular accident—Doxorubicin—kidney cancer	0.000969	0.0026	CcSEcCtD
Carteolol—Hypersensitivity—Sunitinib—kidney cancer	0.000967	0.0026	CcSEcCtD
Carteolol—Palpitations—Paclitaxel—kidney cancer	0.000955	0.00257	CcSEcCtD
Carteolol—Insomnia—Gemcitabine—kidney cancer	0.000953	0.00256	CcSEcCtD
Carteolol—Headache—Erlotinib—kidney cancer	0.00095	0.00255	CcSEcCtD
Carteolol—Loss of consciousness—Paclitaxel—kidney cancer	0.00095	0.00255	CcSEcCtD
Carteolol—Diplopia—Doxorubicin—kidney cancer	0.000949	0.00255	CcSEcCtD
Carteolol—Asthenia—Sunitinib—kidney cancer	0.000942	0.00253	CcSEcCtD
Carteolol—Dyspnoea—Gemcitabine—kidney cancer	0.000939	0.00252	CcSEcCtD
Carteolol—Nausea—Vinblastine—kidney cancer	0.000937	0.00252	CcSEcCtD
Carteolol—Nausea—Everolimus—kidney cancer	0.000934	0.00251	CcSEcCtD
Carteolol—Hypersensitivity—Dactinomycin—kidney cancer	0.000916	0.00246	CcSEcCtD
Carteolol—Arrhythmia—Capecitabine—kidney cancer	0.00091	0.00245	CcSEcCtD
Carteolol—Dizziness—Sorafenib—kidney cancer	0.000902	0.00242	CcSEcCtD
Carteolol—Nausea—Erlotinib—kidney cancer	0.000901	0.00242	CcSEcCtD
Carteolol—Asthenia—Dactinomycin—kidney cancer	0.000892	0.0024	CcSEcCtD
Carteolol—Oedema—Paclitaxel—kidney cancer	0.000882	0.00237	CcSEcCtD
Carteolol—Dysgeusia—Capecitabine—kidney cancer	0.000868	0.00233	CcSEcCtD
Carteolol—Dizziness—Sunitinib—kidney cancer	0.000868	0.00233	CcSEcCtD
Carteolol—Shock—Paclitaxel—kidney cancer	0.000868	0.00233	CcSEcCtD
Carteolol—Headache—Sorafenib—kidney cancer	0.000855	0.0023	CcSEcCtD
Carteolol—Vision blurred—Capecitabine—kidney cancer	0.000836	0.00225	CcSEcCtD
Carteolol—Hypotension—Paclitaxel—kidney cancer	0.000824	0.00221	CcSEcCtD
Carteolol—Headache—Sunitinib—kidney cancer	0.000822	0.00221	CcSEcCtD
Carteolol—Hypersensitivity—Vincristine—kidney cancer	0.000818	0.0022	CcSEcCtD
Carteolol—Nausea—Sorafenib—kidney cancer	0.00081	0.00218	CcSEcCtD
Carteolol—Insomnia—Paclitaxel—kidney cancer	0.000798	0.00214	CcSEcCtD
Carteolol—Asthenia—Vincristine—kidney cancer	0.000797	0.00214	CcSEcCtD
Carteolol—Syncope—Capecitabine—kidney cancer	0.000795	0.00214	CcSEcCtD
Carteolol—Dyspnoea—Paclitaxel—kidney cancer	0.000786	0.00211	CcSEcCtD
Carteolol—Palpitations—Capecitabine—kidney cancer	0.000784	0.00211	CcSEcCtD
Carteolol—Nausea—Sunitinib—kidney cancer	0.00078	0.0021	CcSEcCtD
Carteolol—Loss of consciousness—Capecitabine—kidney cancer	0.000779	0.00209	CcSEcCtD
Carteolol—Asthenia—Gemcitabine—kidney cancer	0.000756	0.00203	CcSEcCtD
Carteolol—Nausea—Dactinomycin—kidney cancer	0.000738	0.00198	CcSEcCtD
Carteolol—Dizziness—Vincristine—kidney cancer	0.000734	0.00197	CcSEcCtD
Carteolol—Oedema—Capecitabine—kidney cancer	0.000724	0.00194	CcSEcCtD
Carteolol—Shock—Capecitabine—kidney cancer	0.000712	0.00191	CcSEcCtD
Carteolol—Conjunctivitis—Doxorubicin—kidney cancer	0.000711	0.00191	CcSEcCtD
Carteolol—Headache—Vincristine—kidney cancer	0.000696	0.00187	CcSEcCtD
Carteolol—Sinusitis—Doxorubicin—kidney cancer	0.000686	0.00184	CcSEcCtD
Carteolol—Hypotension—Capecitabine—kidney cancer	0.000676	0.00182	CcSEcCtD
Carteolol—Bradycardia—Doxorubicin—kidney cancer	0.000668	0.0018	CcSEcCtD
Carteolol—Headache—Gemcitabine—kidney cancer	0.00066	0.00177	CcSEcCtD
Carteolol—Nausea—Vincristine—kidney cancer	0.00066	0.00177	CcSEcCtD
Carteolol—Insomnia—Capecitabine—kidney cancer	0.000655	0.00176	CcSEcCtD
Carteolol—Hypersensitivity—Paclitaxel—kidney cancer	0.00065	0.00175	CcSEcCtD
Carteolol—Dyspnoea—Capecitabine—kidney cancer	0.000645	0.00173	CcSEcCtD
Carteolol—Visual impairment—Doxorubicin—kidney cancer	0.000633	0.0017	CcSEcCtD
Carteolol—Asthenia—Paclitaxel—kidney cancer	0.000633	0.0017	CcSEcCtD
Carteolol—Nausea—Gemcitabine—kidney cancer	0.000626	0.00168	CcSEcCtD
Carteolol—Arrhythmia—Doxorubicin—kidney cancer	0.000587	0.00158	CcSEcCtD
Carteolol—Dizziness—Paclitaxel—kidney cancer	0.000583	0.00157	CcSEcCtD
Carteolol—Dysgeusia—Doxorubicin—kidney cancer	0.00056	0.0015	CcSEcCtD
Carteolol—Headache—Paclitaxel—kidney cancer	0.000552	0.00148	CcSEcCtD
Carteolol—Vision blurred—Doxorubicin—kidney cancer	0.000539	0.00145	CcSEcCtD
Carteolol—Hypersensitivity—Capecitabine—kidney cancer	0.000533	0.00143	CcSEcCtD
Carteolol—Nausea—Paclitaxel—kidney cancer	0.000524	0.00141	CcSEcCtD
Carteolol—Asthenia—Capecitabine—kidney cancer	0.000519	0.0014	CcSEcCtD
Carteolol—Syncope—Doxorubicin—kidney cancer	0.000513	0.00138	CcSEcCtD
Carteolol—Palpitations—Doxorubicin—kidney cancer	0.000505	0.00136	CcSEcCtD
Carteolol—Loss of consciousness—Doxorubicin—kidney cancer	0.000502	0.00135	CcSEcCtD
Carteolol—Dizziness—Capecitabine—kidney cancer	0.000479	0.00129	CcSEcCtD
Carteolol—Oedema—Doxorubicin—kidney cancer	0.000467	0.00125	CcSEcCtD
Carteolol—Shock—Doxorubicin—kidney cancer	0.000459	0.00123	CcSEcCtD
Carteolol—Headache—Capecitabine—kidney cancer	0.000453	0.00122	CcSEcCtD
Carteolol—Hypotension—Doxorubicin—kidney cancer	0.000436	0.00117	CcSEcCtD
Carteolol—Nausea—Capecitabine—kidney cancer	0.00043	0.00116	CcSEcCtD
Carteolol—Insomnia—Doxorubicin—kidney cancer	0.000422	0.00113	CcSEcCtD
Carteolol—Dyspnoea—Doxorubicin—kidney cancer	0.000416	0.00112	CcSEcCtD
Carteolol—Nadolol—ABCB1—kidney cancer	0.000357	0.503	CrCbGaD
Carteolol—Hypersensitivity—Doxorubicin—kidney cancer	0.000344	0.000924	CcSEcCtD
Carteolol—Asthenia—Doxorubicin—kidney cancer	0.000335	0.000899	CcSEcCtD
Carteolol—Dizziness—Doxorubicin—kidney cancer	0.000308	0.000829	CcSEcCtD
Carteolol—Headache—Doxorubicin—kidney cancer	0.000292	0.000785	CcSEcCtD
Carteolol—Nausea—Doxorubicin—kidney cancer	0.000277	0.000745	CcSEcCtD
Carteolol—Propranolol—CYP1A1—kidney cancer	0.000231	0.325	CrCbGaD
Carteolol—Propranolol—ABCB1—kidney cancer	0.000123	0.173	CrCbGaD
